New study aims to predict breast cancer subtypes using imaging alone
NCT ID NCT07354490
First seen Jan 22, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study looks at whether mammograms and ultrasounds can accurately predict the molecular subtype of breast cancer (like Luminal A, HER2-enriched, or triple-negative) without needing a biopsy. Researchers will compare imaging features to standard tissue tests in 122 women with suspected or confirmed breast cancer. The goal is to see if non-invasive imaging can reliably guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.